Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
ASP3026 inhibits ALK, with activity against ALK fusions and mutations, and ROS1, potentially resulting in decreased viability of tumor cells and reduced tumor growth (PMID: 24419060, PMID: 29491259, PMID: 26964870, PMID: 31177400).
|DrugClasses||ALK Inhibitor 25 ROS1 Inhibitor 15|
|CAS Registry Number||1097917-15-1|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|